Metraipolis › archive › dc_7bb861f314ac

Cardiovascular adverse events associated with bispecific antibodies in relapsed or refractory B-cell non-Hodgkin lymphomas — Europe PMC PMID:42192442

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42192442
DOI
10.1186/s13045-[numero omesso]-3
License (as archived)
solo-consultazione
Archived
2026-11-01T06:47:32.797Z
SHA-256 of the archived text
62815f21f0e43363c91debd729356df487ae234352802f8f0243fd62f0452341
Stable URL of this page
https://metraipolis.com/documento/dc_7bb861f314ac

How to cite

Cardiovascular adverse events associated with bispecific antibodies in relapsed or refractory B-cell non-Hodgkin lymphomas — Europe PMC PMID:42192442 — Europe PMC (en), https://europepmc.org/article/MED/42192442 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7bb861f314ac (Metraipolis archive dc_7bb861f314ac, sha256 62815f21f0e43363c91debd729356df487ae234352802f8f0243fd62f0452341)
BibTeX
@misc{dc7bb861f314ac,
  title = {Cardiovascular adverse events associated with bispecific antibodies in relapsed or refractory B-cell non-Hodgkin lymphomas — Europe PMC PMID:42192442},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42192442},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7bb861f314ac; sha256 62815f21f0e43363c91debd729356df487ae234352802f8f0243fd62f0452341},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42192442. Agents can read the archived copy with the MCP tool read_document.